Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Postpartum Hemorrhage Among Women with an Undiagnosed Bleeding Disorder, Potential Extramural Projects (PEP) 2008-R-28, 21138 [E8-8407]
Download as PDF
<![CDATA[
21138
Federal Register / Vol. 73, No. 76 / Friday, April 18, 2008 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Centers for Disease Control and
Prevention
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time and Date: 1 p.m.–2 p.m., May 16,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Postpartum Hemorrhage
Among Women with an Undiagnosed
Bleeding Disorder, PEP 2008–R–28.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Time and Date: 1 p.m.–2:30 p.m., May 22,
2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Evaluation of Breastfeeding
Promotion and Support Programs for AfricanAmerican Women, PEP 2008–R–25.’’
Contact Person for More Information:
Linda Shelton, Program Specialist,
Coordinating Center for Health and
Information Service, Office of the Director,
CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498–
1194.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8438 Filed 4–17–08; 8:45 am]
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Postpartum
Hemorrhage Among Women with an
Undiagnosed Bleeding Disorder,
Potential Extramural Projects (PEP)
2008–R–28
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E8–8407 Filed 4–17–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
pwalker on PROD1PC71 with NOTICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Evaluation of
Breastfeeding Promotion and Support
Programs for African-American
Women, Potential Extramural Project
(PEP) 2008–R–25
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
VerDate Aug<31>2005
17:38 Apr 17, 2008
Jkt 214001
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10260]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
AGENCY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Medicare
Advantage (MA) Disclosure
Requirements; Use: The information
collection requirements are mandated
by 42 CFR 422.111 and 422.80. MA
organizations will be required to notify
plan members of the coming year’s
changes using a combined standardized
document. MA organizations and
potential MA organizations (applicants)
will use the information to comply with
the eligibility requirements and the MA
contract requirements. CMS will use
this information to ensure that correct
information is disclosed to Medicare
beneficiaries, both potential enrollees
and enrollees. Form Number: CMS–
10260 (OMB# 0938–New); Frequency:
Yearly; Affected Public: Business or
other for-profit; Number of
Respondents: 670; Total Annual
Responses: 670; Total Annual Hours:
8040.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by June 17, 2008:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address:
CMS, Office of Strategic Operations
and Regulatory Affairs, Division of
Regulations Development, Attention:
Document Identifier/OMB Control
Number lll, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
E:\FR\FM\18APN1.SGM
18APN1
]]>Agencies
[Federal Register Volume 73, Number 76 (Friday, April 18, 2008)]
[Notices]
[Page 21138]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-8407]
[[Page 21138]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Postpartum Hemorrhage Among Women with an
Undiagnosed Bleeding Disorder, Potential Extramural Projects (PEP)
2008-R-28
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 1 p.m.-2 p.m., May 16, 2008 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of ``Postpartum Hemorrhage Among Women
with an Undiagnosed Bleeding Disorder, PEP 2008-R-28.''
Contact Person for More Information: Linda Shelton, Program
Specialist, Coordinating Center for Health and Information Service,
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498-1194.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: April 10, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E8-8407 Filed 4-17-08; 8:45 am]
BILLING CODE 4163-18-P
